$270 million for new medicine to benefit thousands of Australians with severe eczema
Australians suffering from a severe form of eczema will now have access to a life changing medicine through the Pharmaceutical Benefits Scheme (PBS) which will provide hope and relief to many young Australians and their families. From Monday 1 March 2021 the medicine Dupixent® (dupilumab) will be available to Australians over 12 years of age living…